Relative Abundance Analysis of the Oral and Gastrointestinal Microbiome during Autologous Transplantation for Multiple Myeloma: Results of a Prospective Pilot Study and Association with Transplant Outcomes

被引：0
|
作者：
El Jurdi, Najla H. [1 ]
Filali, Ali [2 ]
Salem, Iman [2 ]
Retuerto, Mauricio [2 ]
Dambrosio, Nina [3 ]
Lazarus, Hillard M. [4 ]
Creger, Richard [3 ]
Caimi, Paolo F. [5 ]
Cooper, Brenda [2 ,6 ]
Tomlinson, Ben [7 ]
Metheny, Leland [8 ]
Malek, Ehsan [3 ]
Otegbeye, Folashade [7 ]
Sekaly, Rafick-Pierre [2 ]
Ghannoum, Mahmoud [2 ]
de Lima, Marcos [7 ]
机构：
[1] Univ Minnesota, Hematol Oncol & Transplantat, Minneapolis, MN USA
[2] Case Western Reserve Univ, Cleveland, OH 44106 USA
[3] Univ Hosp Cleveland, Med Ctr, Seidman Canc Ctr, Adult Hematol Malignancies & Stem Cell Transplant, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[5] Univ Hosp Cleveland, Adult Hematol Malignancies & Stem Cell Transplant, Cleveland, OH 44106 USA
[6] Univ Hosp Seidman Canc Ctr, Hematol Malignancies Program, Cleveland, OH USA
[7] Univ Hosp Seidman Canc Ctr, Adult Hematol Malignancies Stem Cell Transplant S, Cleveland, OH USA
[8] Univ Hosp Cleveland, Med Ctr, Stem Cell Transplant Program, Cleveland, OH 44106 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-120125
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5754
引用
收藏
页数：3
相关论文
共 47 条
  • [41] RETRACTED: Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study (Retracted Article)
    Hansen, Per Boye
    Penkowa, Milena
    SUPPORTIVE CARE IN CANCER, 2017, 25 (04) : 1279 - 1289
  • [42] Low Non Relapse Mortality and Good Hematological Response after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients with Renal Insufficiency at Transplant: A Prospective Societe Francaise De Greffe De Moelle-Therapie Cellulaire Observational Study
    Garderet, Laurent
    Ouldjeriouat, Hafida
    Bekadja, Mohamed-Amine
    Daguenet, Elisabeth
    Vincent, Laure
    Weil, Damien Roos
    Vignon, Marguerite
    Mohty, Mohamad
    Abraham, Julie
    Escoffre-Barbe, Martine
    Lioure, Bruno
    Nacer, Redhouane Ahmed
    Caillot, Denis
    Mariette, Clara
    Karlin, Lionel
    Morel, Pierre
    Gilis, Lila
    Leray, Emanuelle
    Blouet, Anaise
    Raus, Nicole
    Robin, Marie
    Boffa, Jean Jacques
    Ronco, Pierre
    Rubio, Marie Therese
    Lambert, Jerome
    Cornillon, Jerome
    BLOOD, 2022, 140 : 7219 - 7221
  • [43] Persistent Improvement In Clinical Outcomes With Bortezomib-Thalidomide-Dexamethasone Vs Thalidomide-Dexamethasone Incorporated Into Double Autologous Transplantation For Multiple Myeloma: An Updated Analysis Of Phase 3 Gimema-MMY-3006 Study
    Cavo, Michele
    Galli, Monica
    Pezzi, Annalisa
    Di Raimondo, Francesco
    Crippa, Claudia
    Offidani, Massimo
    Tacchetti, Paola
    Montefusco, Vittorio
    Narni, Franco
    Spadano, Antonio
    Pescosta, Norbert
    Zamagni, Elena
    Gamberi, Barbara
    Caravita, Tommaso
    Falcone, Antonietta Pia
    Nozzoli, Chiara
    Zambello, Renato
    Furlan, Anna
    Brioli, Annamaria
    Boccadoro, Mario
    BLOOD, 2013, 122 (21)
  • [44] Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Societe Francophone de Greffe de Moelle-Therapie Cellulaire observational study
    Garderet, Laurent
    Ouldjeriouat, Hafida
    Bekadja, Mohamed-Amine
    Daguenet, Elisabeth
    Bigot, Noemie
    Vincent, Laure
    Roos-Weil, Damien
    Vignon, Marguerite
    Ikhlef, Souhila
    Abraham, Julie
    Escoffre-Barbe, Martine
    Lioure, Bruno
    Nacer, Redhouane Ahmed
    Lafon, Ingrid
    Mariette, Clara
    Karlin, Lionel
    Morel, Pierre
    Gilis, Lila
    Le Ray, Emanuelle
    Blouet, Anaise
    Nguyen Quoc, Stephanie
    Boffa, Jean Jacques
    Ronco, Pierre
    Lambert, Jerome
    Cornillon, Jerome
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1450 - 1458
  • [45] RETRACTION: Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study (Retraction of Vol 25, Pg 1279, 2017)
    Hansen, Per Boye
    Penkowa, Milena
    SUPPORTIVE CARE IN CANCER, 2021, 29 (01) : 533 - 534
  • [46] Bortezomib-Thalidomide-Dexamethasone Versus Thalidomide-Dexamethasone before and after Double Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase 3 Gimema-MMY-3006 Study and Prognostic Score for Survival Outcomes
    Tacchetti, Paola
    Dozza, Luca
    Di Raimondo, Francesco
    Crippa, Claudia
    Zamagni, Elena
    Bringhen, Sara
    Pantani, Lucia
    Offidani, Massimo
    Montefusco, Vittorio
    Narni, Franco
    Mancuso, Katia
    Cellini, Claudia
    Spadano, Antonio
    Pescosta, Norbert
    Baldini, Luca
    Terragna, Carolina
    Nozzoli, Chiara
    Zambello, Renato
    Derudas, Daniele
    Ballanti, Stelvio
    Cavo, Michele
    BLOOD, 2018, 132
  • [47] Interim PK analysis results of a phase IIa, open-label, randomized, pharmacokinetic comparative, cross-over study of melphalan HCl for injection (propylene glycol-free) and alkeran for injection for myeloablative conditioning in multiple myeloma patients undergoing autologous transplantation
    Aljitawi, O. S.
    Ganguly, S.
    Abhyankar, S. H.
    Robinson, D.
    Marks, R.
    Pipkin, J.
    McGuirk, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345